A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

BACKGROUND: HIV-infected, treatment-experienced adults with a history of prior resistance and regimen failure can be virologically suppressed but may require multitablet regimens associated with lower adherence and potential resistance development. METHODS: We enrolled HIV-infected, virologically su...

Descripción completa

Detalles Bibliográficos
Autores principales: Huhn, Gregory D., Tebas, Pablo, Gallant, Joel, Wilkin, Timothy, Cheng, Andrew, Yan, Mingjin, Zhong, Lijie, Callebaut, Christian, Custodio, Joseph M., Fordyce, Marshall W., Das, Moupali, McCallister, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2017
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228611/
https://www.ncbi.nlm.nih.gov/pubmed/27753684
http://dx.doi.org/10.1097/QAI.0000000000001193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228611/
https://www.ncbi.nlm.nih.gov/pubmed/27753684
http://dx.doi.org/10.1097/QAI.0000000000001193

Ejemplares similares